COSTANTINI, C., E. NUNZI, A. SPOLZINO, F. MERLI, L. FACCHINI, A. SPADEA, L. MELILLO, K. CODELUPPI, F. MARCHESI, G. MARCHESINI, D. VALENTE, G. DRAGONETTI, G. NADALI, Lukas ENGLMAIER, Kateřina COUFALÍKOVÁ, Zdeněk SPÁČIL, M.M. BELLET, M. PARIANO, G. RENGA, C. STINCARDINI, F. D'ONOFRIO, S. BOZZA, L. PAGANO, F. AVERSA and L. ROMANI. A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants. INFECTION AND IMMUNITY. WASHINGTON: American Society for Microbiology, 2022, vol. 90, No 4, p. 1-14. ISSN 0019-9567. Available from: https://dx.doi.org/10.1128/iai.00048-22.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants
Authors COSTANTINI, C., E. NUNZI, A. SPOLZINO, F. MERLI, L. FACCHINI, A. SPADEA, L. MELILLO, K. CODELUPPI, F. MARCHESI, G. MARCHESINI, D. VALENTE, G. DRAGONETTI, G. NADALI, Lukas ENGLMAIER, Kateřina COUFALÍKOVÁ (203 Czech Republic, belonging to the institution), Zdeněk SPÁČIL (203 Czech Republic, guarantor, belonging to the institution), M.M. BELLET, M. PARIANO, G. RENGA, C. STINCARDINI, F. D'ONOFRIO, S. BOZZA, L. PAGANO, F. AVERSA and L. ROMANI.
Edition INFECTION AND IMMUNITY, WASHINGTON, American Society for Microbiology, 2022, 0019-9567.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.100
RIV identification code RIV/00216224:14310/22:00126195
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1128/iai.00048-22
UT WoS 000786356100013
Keywords in English hematological malignancies; invasive fungal infection; nasal microbiome; tryptophan; kynurenine; tolerance
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michaela Hylsová, Ph.D., učo 211937. Changed: 1/7/2022 21:43.
Abstract
It is becoming increasingly clear that the communities of microorganisms that populate the surfaces exposed to the external environment, termed microbiota, are key players in the regulation of pathogen-host cross talk affecting the onset as well as the outcome of infectious diseases. We have performed a multicenter, prospective, observational study in which nasal and oropharyngeal swabs were collected for microbiota predicting the risk of invasive fungal infections (IFIs) in patients with hematological malignancies. Here, we demonstrate that the nasal and oropharyngeal microbiota are different, although similar characteristics differentiate high-risk from low-risk samples at both sites. Indeed, similar to previously published results on the oropharyngeal microbiota, high-risk samples in the nose were characterized by low diversity, a loss of beneficial bacteria, and an expansion of potentially pathogenic taxa, in the presence of reduced levels of tryptophan (Trp). At variance with oropharyngeal samples, however, low Trp levels were associated with defective host-derived kynurenine production, suggesting reduced tolerance mechanisms at the nasal mucosal surface. This was accompanied by reduced levels of the chemokine interleukin-8 (IL-8), likely associated with a reduced recruitment of neutrophils and impaired fungal clearance. Thus, the nasal and pharyngeal microbiomes of hematological patients provide complementary information that could improve predictive tools for the risk of IFI in hematological patients.
Links
EF15_003/0000469, research and development projectName: Cetocoen Plus
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
GJ17-24592Y, research and development projectName: Mapování interakcí mezi základními metabolickými pochody a střevní mikroflórou
Investor: Czech Science Foundation
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
857560, interní kód MU
(CEP code: EF17_043/0009632)
Name: CETOCOEN Excellence (Acronym: CETOCOEN Excellence)
Investor: European Union, Spreading excellence and widening participation
PrintDisplayed: 27/7/2024 18:11